The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells

Marina Vilaseca(Centre for Biomedical Network Research on Rare Diseases), Juan Carlos García‐Pagán(Instituto de Salud Carlos III)
Hepatology
January 31, 2017
Cited by 115


Related Papers